Ensysce Biosciences Inc

NASDAQ:ENSC   10:45:25 AM EDT
0.52
0.00 (+0.10%)
Earnings Announcements

Ensysce Biosciences Provides Business Update And Reports Fourth Quarter And Full Year 2021 Financial Results

Published: 03/31/2022 20:31 GMT
Ensysce Biosciences Inc (ENSC) - Ensysce Biosciences Provides Business Update and Reports Fourth Quarter and Full Year 2021 Financial Results.
Ensysce Biosciences Inc - Cash and Cash Equivalents Were $12.3 Million As of December 31, 2021.
Ensysce Biosciences Inc - Qtrly Loss per Share $0.45.
Revenue is expected to be $1 Million
Adjusted EPS is expected to be -$0.17

Next Quarter Revenue Guidance is expected to be $1.1 Million
Next Quarter EPS Guidance is expected to be -$0.18

More details on our Analysts Page.